Literature DB >> 1248008

Effect of N1-(2'-tetrahydrofuryl)-5-fluorouracil and 5-fluorouracil on nucleic acid and protein biosyntheses in Ehrlich ascites cells.

S Fujimoto, T Akao, B Itoh, I Koshizuka, K Koyano.   

Abstract

N1-(2'-Tetrahydrofuryl)-5-fluorouracil (FT-207) is a derivative of 5-fluorouracil (5-FU) and has been accepted as a new chemotherapeutic drug. The inhibitory effects of FT-207 and 5-FU on nucleic acid and protein biosyntheses in Ehrlich ascites cells were compared. Both drugs markedly inhibited the incorporation in vivo of the labeled precursors into nucleic acid and protein. The inhibitory effect of FT-207 on DNA and RNA synthesis lasted for a long period of time. Two hr after administration of 5-FU (250 mug/g body weight), the absolute size of uracil pool of liver increased by at least 50%. However, in an in vitro study, FT-207 at a concentration of 60 mug/ml produced no effect on the incorporation of precursors into DNA and RNA of Ehrlich ascites cells 3 hr incubation. If 5-FU was added to Ehrlich ascites cell suspension simultaneously with [5-3H]uridine, the incorporation of the labeled precursor into RNA increased by 30 to 50%.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1248008

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  4 in total

1.  Cytotoxicity of three novel fluoropyrimidines in cultured L1210 murine lymphocytic leukemia cells.

Authors:  A M Shipp; M H Holshouser; P W Ferguson
Journal:  Pharm Res       Date:  1990-12       Impact factor: 4.200

2.  Stereoselective metabolism of ftorafur (R,S-1-(tetrahydro-2-furanyl)-5-fluorouracil).

Authors:  J L Au; W Sadée
Journal:  Cancer Chemother Pharmacol       Date:  1981       Impact factor: 3.333

3.  Comparative efficacy of antitumor treatment for liver metastases from colorectal cancer.

Authors:  S Fujimoto; M Miyazaki; Y Kitsukawa; K Okui
Journal:  Jpn J Surg       Date:  1981

4.  Comparing cell kinetic studies of the effect of ftorafur and 5-fluorouracil on the L 1210 ascites tumor.

Authors:  B Schultze; W Jellinghaus; G Weis; V Müller; W Maurer
Journal:  J Cancer Res Clin Oncol       Date:  1981       Impact factor: 4.553

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.